Article
Novel adenovirus vector-based vaccines for HIV-1
15 Jul 2010
Abstract excerpt
PURPOSE OF REVIEW: Recombinant adenovirus (rAd) vectors have emerged as promising vaccine platform technologies due to their capacity to elicit potent humoral and cellular immune responses to encoded antigens. These vectors are being explored as potential vaccine candidates for a variety of pathogens. This review summarizes current efforts to develop rAd vector-based vaccines for HIV-1. RECENT FINDINGS: In the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
